Wedbush Research Analysts Raise Earnings Estimates for FENC
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Analysts at Wedbush upped their Q1 2025 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued on Monday, March 10th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.10) per share for the quarter, up from their previous estimate of […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Analysts at Wedbush upped their Q1 2025 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued on Monday, March 10th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.10) per share for the quarter, up from their previous estimate of […]
